We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Amplification of c-myc by Fluorescence In Situ Hybridization in a Population-Based Breast Cancer Tissue Array.
- Authors
Rummukainen, Jaana K.; Salminen, Tiina; Lundin, Johan; Kytöläa, Soili; Joensuu, Heikki; Isola, Jorma J.
- Abstract
A total of 261 primary breast carcinomas were analyzed for amplification of the c-myc oncogene by fluorescence in situ hybridization performed on tumor tissue array samples. Results were compared with individual clinicopathologic and follow-up data. Thirty-eight (14.6%) of the tumors showed c-myc gene amplification (defined as two or more additional copies of c-myc gene in relation to the number of chromosome 8 centromere). The reproducibility of fluorescence in situ hybridization assay (defined by hybridization with two different myc probes) was good (kappa coefficient 0.402). Statistically significant associations were found between c-myc amplification and DNA aneuploidy (P = .0011), and progesterone receptor negativity (P = .0071), and c-myc amplification also tended to be associated with high histologic grade (P = .064), positive axillary nodal status (P = .080), and a high S-phase fraction (P = .052). c-myc amplification was not significantly associated with overall survival of patients with invasive cancer (P = .32). These data from a population-based tumor material suggest that c-myc amplification is a feature of aggressive breast cancers, but that it is unlikely to be a clinically useful prognostic factor.Mod Pathol 2001;14(10):1030-1035
- Subjects
BREAST cancer; IN situ hybridization; TUMORS; ONCOGENES; CANCER invasiveness; CANCER patients
- Publication
Modern Pathology, 2001, Vol 14, Issue 10, p1030
- ISSN
0893-3952
- Publication type
Article
- DOI
10.1038/modpathol.3880431